Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI Inventory

Raw materials, work in progress, and finished goods held for sale.

Masimo CorporationNASDAQ: MASI

Inventory · Q1 FY2026 · quarter ended Apr 2026

Inventory rises 32.8% from a year ago

Inventory stood at $400M at the end of Q1 FY2026, up 32.8% from a year earlier and up 5.2% from the prior quarter. Over 3 fiscal years it compounded at -8.8% a year.

Context

  • Inventory amounted to 24.4% of total assets at the end of Q1 FY2026, up 11.2 pp from a year earlier.
  • Inventory increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether inventory keeps rising in the next quarterly balance sheet after a +32.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
$400M+5.2% QoQ
Last fiscal yearJan 2026
$380.3M-17.2% YoY
Year agoMar 2025
$301.2M+32.8% since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.8%——
1 year-17.2%——
3-year CAGR-8.8%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the balance sheet

Latest · FY2025
380.3M USD
Year-over-year change
-17.2%
4-year CAGR
+17.2%

Inventory vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so inventory is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +32.8% is the 2nd highest of 9, against a peer median of +9.0%.
  • Inventory amounts to 24.4% of total assets for MASI, versus a peer median of 7.4%.
MASI Competitors
Inventory for MASI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BAXBaxter International Inc.Jun 2026$2.26B USD-5.2%-5.9%11.4%
HSICHenry Schein, Inc.Jun 2026$2.06B USD+7.9%+0.7%18.1%
AVTRAvantor, Inc.Jun 2026$828.7M USD+6.3%-3.6%7.1%
BIOBio-Rad Laboratories, Inc.Jun 2026$780.6M USD-2.3%+1.0%7.6%
ATRAptarGroup, Inc.Jun 2026$580.14M USD+10.0%+3.4%11.3%
MASIMasimo CorporationApr 2026$400M USD+32.8%-8.8%24.4%
STVNStevanato Group S.p.A.Jun 2026€309M EUR+12.7%+7.9%11.8%
RGENRepligen CorporationJun 2026$186.6M USD+19.7%-10.6%6.3%
RYTMRhythm Pharmaceuticals, Inc.Sep 2026$31.19M USD+41.1%+106.7%7.0%
MOHMolina Healthcare, Inc.Sep 2026$0 USD——0.0%
ABVXAbivax S.A.Jun 2026€0 EUR——0.0%
Peer median (excluding MASI) —+9.0%+0.8%7.4%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Cash & Equivalents745.3M202.9M163M177.6M152.3M
Short-term Investments00000
Net Receivables244.69M505.1M421M489.3M327.5M
Inventory201.4M501M545M459.2M380.3M
Other Current Assets6.7M6M10.5M24.4M3.9M
Total Current Assets1.24B1.31B1.23B1.23B926M
Property, Plant & Equipment (Net)303.3M472.1M483.5M456M355.1M
Goodwill100.3M445.4M407.7M96.7M101M
Intangible Assets72.5M722.6M652.3M558.2M52.1M
Long-term Investments13.8M13.8M9.9M8.6M71.3M
Tax Assets52.6M102.5M107.2M143.6M114.2M
Other Non-current Assets105.6M145.6M149M136.8M79.2M
Total Non-current Assets648.1M1.9B1.81B1.4B772.9M
Total Assets1.89B3.21B3.04B2.63B1.7B
Account Payables75.6M276.8M251.5M252.8M103M
Short-term Debt015.1M34.3M37.3M6.3M
Tax Payables30.3M72.4M50.2M55.5M0
Deferred Revenue29.9M36M37.4M46.8M38.5M
Other Current Liabilities75.5M95.4M69.3M93.2M88.4M
Total Current Liabilities267.7M630M563.8M617.7M371.6M
Long-term Debt0941.6M871.7M727.9M518M
Deferred Tax Liabilities5.1M163.6M111.7M100.1M26.4M
Deferred Revenue (Non-current)5.2M25M26.4M27.4M23M
Other Non-current Liabilities32.5M58.1M57.3M41.2M11.8M
Total Non-current Liabilities69.1M1.24B1.11B956.1M606.1M
Total Liabilities336.8M1.87B1.68B1.57B977.7M
Common Stock100K100K100K100K100K
Retained Earnings1.57B1.71B1.8B1.49B1.34B
Accumulated OCI(5.5M)11.5M(45.3M)(108.2M)(12.5M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.55B1.34B1.36B1.05B721.2M
Total Debt32.7M1.03B970M846.1M559.3M
Net Debt(712.6M)825.9M807M668.5M407M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.